Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ISPC | US
0.06
26.96%
Healthcare
Diagnostics & Research
30/06/2024
13/03/2026
0.28
0.43
0.44
0.28
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids tissues and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals labs biobanks blood centers and other healthcare organizations. The company develops and operates iSpecimen Marketplace a proprietary online marketplace platform that connects medical researchers who need access to subjects samples and data with hospitals laboratories and other organizations who have access to them. It serves biopharmaceutical companies in vitro diagnostic companies and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington Massachusetts.
View LessStrength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
169.3%1 month
140.3%3 months
132.7%6 months
139.2%-
-
0.44
0.00
0.00
0.43
0.05
-
-10.03M
186.24K
186.24K
-
-76.18
-
76.20
-98.03
0.25
11.03
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.22
Range1M
0.22
Range3M
0.26
Rel. volume
17.71
Price X volume
76.77M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| bioAffinity Technologies Inc. Warrant | BIAFW | Diagnostics & Research | 0.3299 | 0 | 36.10% | n/a | 40.20% |
| STRRP | STRRP | Diagnostics & Research | 10.06 | 0 | 0.20% | n/a | 26.85% |
| Prenetics Holding Company Limited | PRENW | Diagnostics & Research | 0.0202 | 0 | n/a | 0.63% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.43 | 12.67 | Cheaper |
| Ent. to Revenue | 0.05 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.44 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 132.73 | 59.59 | Riskier |
| Debt to Equity | 0.00 | -14.36 | Expensive |
| Debt to Assets | 0.00 | 0.34 | Cheaper |
| Market Cap | 186.24K | 13.71B | Emerging |